Article ; Online: Pentoxifylline in the treatment of neonatal vasospasm and thromboembolism: An observational case series study.
Journal of clinical pharmacy and therapeutics
2021 Volume 47, Issue 4, Page(s) 455–461
Abstract: What is known and objective: Newborns, particularly preterm babies, are prone to vascular vasospasm and thromboembolism. Differences in the haemostatic system, small vessel diameter and presence of any serious diseases are predisposing causes of ... ...
Abstract | What is known and objective: Newborns, particularly preterm babies, are prone to vascular vasospasm and thromboembolism. Differences in the haemostatic system, small vessel diameter and presence of any serious diseases are predisposing causes of thromboembolic disease in newborns. The lack of randomized controlled studies on the management of vasospasm and thromboembolism exacerbates the problem. We present a case series of the successful and safe use of PTX for the treatment of vasospasm and thrombosis in neonates. Methods: The study was conducted in the Bezmialem Vakif University Hospital Neonatal Intensive Care Unit (NICU). A retrospective chart review was performed on consecutive patients treated for vascular spasm and thrombosis. Nine patients diagnosed with vasospasm or thrombosis were enrolled in the study. Results: Five patients had arterial injuries. Six patients were premature, and five patients were diagnosed with thrombosis by using Doppler ultrasonography (US). The drug was diluted with 5% dextrose and administered intravenously at a dose of 5 mg/kg/h over six hours, ranging from 1 to 5 days. No drug-related side effects were observed. All babies recovered, and no amputation was performed. What is new and conclusion: PTX may be an alternative treatment for vascular vasospasm and thromboembolism with fewer side effects than anticoagulant and thrombolytic agents in neonates. Starting PTX in the early stages of vascular insult may prevent the development of vasospasm and thromboembolism and thus limb ischaemia. |
---|---|
MeSH term(s) | Humans ; Infant, Newborn ; Pentoxifylline/therapeutic use ; Retrospective Studies ; Spasm/drug therapy ; Thromboembolism/drug therapy ; Thrombosis/drug therapy |
Chemical Substances | Pentoxifylline (SD6QCT3TSU) |
Language | English |
Publishing date | 2021-11-02 |
Publishing country | England |
Document type | Case Reports ; Journal Article ; Observational Study |
ZDB-ID | 639006-7 |
ISSN | 1365-2710 ; 0269-4727 |
ISSN (online) | 1365-2710 |
ISSN | 0269-4727 |
DOI | 10.1111/jcpt.13565 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1313: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.